A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA)
Clinical trial NCT02373202 · COMPLETED
Trial details
- NCT number
- NCT02373202
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2016-11-01
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.